Ratzon Roy, Reshef Avner, Efrati Ori, Deutch Michal, Forschmidt Rinat, Cukierman-Yaffe Tali, Kenett Ron, Kidon Mona Iancovici
Sackler Medical School, Tel Aviv University, Tel Aviv, Israel.
Allergy and Immunology Unit, Sheba Medical Center, Tel Hashomer, Israel.
Ann Allergy Asthma Immunol. 2016 Apr;116(4):329-33. doi: 10.1016/j.anai.2016.01.018. Epub 2016 Feb 26.
Drug provocation tests (DPTs) are the gold standard in the diagnosis of β-lactam hypersensitivity. However, no consensus exists on the need for extended provocation tests, even though the effectiveness of the short DPT is relatively low and there has been an increase in the relative incidence of nonimmediate hypersensitivity reactions.
To evaluate the effectiveness of a 7-day (extended) DPT compared with a 1-day-only (short) DPT in the management of hypersensitivity reactions to β-lactam antibiotics.
Patients referred to the allergy clinic of the Sheba Medical Center for suspected β-lactam hypersensitivity from January 2008 to December 2012 underwent in vivo skin tests and an immediate short DPT with the culprit drug. Unless an immediate reaction was clearly documented, patients were offered a 7-day, extended DPT. Long-term effectiveness, calculated as the subsequent use of the tested antibiotic, and satisfaction levels were assessed with a telephone questionnaire.
Of 49 negative DPT results, 26 (53%) were long and 23 (47%) were short. A total of 78% of the patients who underwent the long DPT reported that they used the drug compared with 61% of those who underwent only the short DPT (P = .049). Most patients were very satisfied with the drug allergy evaluation process.
An extended DPT protocol increased the effectiveness of the allergy workup in our center without compromising patient satisfaction and safety, and it should be recommended to patients with a history of nonimmediate reaction to β-lactam.
药物激发试验(DPT)是诊断β-内酰胺类药物超敏反应的金标准。然而,对于延长激发试验的必要性尚无共识,尽管短程DPT的有效性相对较低,且非速发型超敏反应的相对发生率有所增加。
评估7天(延长)DPT与仅1天(短程)DPT在管理β-内酰胺类抗生素超敏反应中的有效性。
2008年1月至2012年12月转诊至舍巴医疗中心过敏门诊怀疑β-内酰胺类药物超敏反应的患者接受了体内皮肤试验及对可疑药物的即时短程DPT。除非有明确记录的即时反应,患者会接受7天的延长DPT。通过电话问卷调查评估以随后使用受试抗生素计算的长期有效性及满意度。
49例DPT结果为阴性的患者中,26例(53%)为长程,23例(47%)为短程。接受长程DPT的患者中共有78%报告他们使用了该药物,而仅接受短程DPT的患者中这一比例为61%(P = 0.049)。大多数患者对药物过敏评估过程非常满意。
延长DPT方案提高了我们中心过敏检查的有效性,且不影响患者满意度和安全性,对于有β-内酰胺类非速发型反应病史的患者应推荐使用。